350352 <common-name>3-[1-[1-[[3-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-(4-cyanophenyl)methyl]azetidin-3-yl]-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile</common-name> <description>3-[1-[1-[[3-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-(4-cyanophenyl)methyl]azetidin-3-yl]-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile is a chemical compound with the formula C30H26F2N6O. With an average molecular weight of 524.60 g/mol, 3-[1-[1-[[3-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-(4-cyanophenyl)methyl]azetidin-3-yl]-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>68977099</pubchem-id> <chemical-formula>C30H26F2N6O</chemical-formula> <weight>524.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:22:23Z</created-at> <updated-at type="dateTime">2026-08-31T15:22:23Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)(C(C1CN(C1)C(C2=CC=C(C=C2)C#N)C3=CC=CC(=C3)C4=NN=C(O4)N)C5=CC(=CC(=C5)C#N)F)F</moldb-smiles> <moldb-formula>C30H26F2N6O</moldb-formula> <moldb-inchi>InChI=1S/C30H26F2N6O/c1-30(2,32)26(23-10-19(15-34)11-25(31)13-23)24-16-38(17-24)27(20-8-6-18(14-33)7-9-20)21-4-3-5-22(12-21)28-36-37-29(35)39-28/h3-13,24,26-27H,16-17H2,1-2H3,(H2,35,37)</moldb-inchi> <moldb-inchikey>AKSVEYGFHNXCSL-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">524.2136158</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346245</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[1-[1-[[3-(5-amino-1,3,4-oxadiazol-2-yl)phenyl]-(4-cyanophenyl)methyl]azetidin-3-yl]-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom nil="true"/> <superklass nil="true"/> <klass nil="true"/> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0300659</sync-id> <structure-inchikey>AKSVEYGFHNXCSL-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400100002800010000000000020060004000000000000800824000100000000000000000000040000000000000000021008000000000000800040000000000000000000000000000000000000000000000008000a0000010200000009000100100000220000200000000000000100000000000020100000000000000000000100101010040002000800000000000800000881000000000000000000000004000000000000040000000000400088004000000000000044000000000000000000000000000000400000800000000000000020000000000000000000200000000000000000000100004000040000000000000800000200000200000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKwAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAQMGAGAAAAADAQYAYAAAAAMBBgBgAAAAAgIHACAAAAADBgBgAAAA AgIGAGAAAAADAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQG QGgAAAADAwEGQGgAAAADAwEGACgAAAACBAcAKAAAAAIDBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAKAAA AAMEB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMECEAoAAAAAwIHAGgAAAADAQIG QCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQGQGgA AAADAwEGACgAAAACBAcAKAAAAAIDCQAgAAAAAQkAIAAAAAELAAEAAQIAAQMA AwQABAUABQYABgcABggACAkACQpoDAoLaAwLDGgMDA1oDA0OaAwMDyAPECgD CBEAERJoDBITaAwTFGgMFBVoDBUWaAwVFyAXGGgMGBloDBkaaAwaG2gMGhwg Ax0AHR5oDB4faAwfIGgMICFoDCEiaAwhIyAjJCgDHyUAASYABwQADgloDBYR aAwbF2gMIh1oDEIFAAAABAUGBwQGCgsMDQ4JBhITFBUWEQUYFxsaGQYeHyAh Ih0XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:20Z</structure-indexed-at> </compound>